PubRank
Search
About
John P Donohue
Author PubWeight™ 14.45
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.
J Urol
2007
1.53
2
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee.
Arthritis Res Ther
2011
1.12
3
Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
J Urol
2009
1.07
4
Crystal structures of complexes containing domains from two viral internal ribosome entry site (IRES) RNAs bound to the 70S ribosome.
Proc Natl Acad Sci U S A
2011
1.06
5
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.
J Urol
2002
1.05
6
Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
Cancer
2007
1.04
7
Histology in mixed germ cell tumors. Is there a favorite pairing?
J Urol
2004
0.96
8
Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
J Clin Oncol
2005
0.95
9
Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
J Urol
2003
0.93
10
Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
Cancer
2003
0.93
11
Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
J Urol
2004
0.90
12
Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer.
Urol Oncol
2005
0.79
13
Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?
J Urol
2005
0.79
14
Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor.
J Urol
2005
0.79
15
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome.
Urol Clin North Am
2007
0.77
16
Retroperitoneal lymph node dissection in testicular cancer.
Surg Oncol Clin N Am
2007
0.75
17
The role of retroperitoneal surgery in testis cancer.
Crit Rev Oncol Hematol
2002
0.75
18
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Urology
2007
0.75
19
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
J Urol
2007
0.75